Advertisement

Topics

New Biomarker Signals Poor Response in Prostate Cancer

08:54 EDT 4 May 2017 | Medscape

A new test identifies men with castration-resistant prostate cancer who have a poorer response to abiraterone and enzalutamide.
Medscape Medical News

Original Article: New Biomarker Signals Poor Response in Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "New Biomarker Signals Poor Response in Prostate Cancer"

Quick Search
Advertisement
 

Relevant Topic

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...